N-(1,2,2,2-Tetrachloraethyl)-α-furoamid | 39635-63-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-(1,2,2,2-Tetrachloraethyl)-α-furoamid
• 英文别名: N-(1,2,2,2-Tetrachloroethyl)-2-furancarboxamide；N-(1,2,2,2-tetrachloroethyl)furan-2-carboxamide
• CAS: 39635-63-7
• 化学式: C₇H₅Cl₄NO₂
• 分子量: 276.934
• InChiKey: JWWLARNWZPQPQR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-(1,2,2,2-Tetrachloraethyl)-α-furoamid 在 sodium hydrogen sulfide 作用下， 以 苯 为溶剂， 生成 [2-(Furan-2-yl)-5-prop-2-enylsulfanyl-1,3-oxazol-4-yl]-triphenylphosphanium;iodide
  参考文献：
  名称：

  In silico and in vitro studies of a number PILs as new antibacterials against MDR clinical isolate Acinetobacter baumannii

  摘要：

  AbstractQSAR analysis of a set of previously synthesized phosphonium ionic liquids (PILs) tested against Gram‐negative multidrug‐resistant clinical isolate Acinetobacter baumannii was done using the Online Chemical Modeling Environment (OCHEM). To overcome the problem of overfitting due to descriptor selection, fivefold cross‐validation with variable selection in each step of the model development was applied. The predictive ability of the classification models was tested by cross‐validation, giving balanced accuracies (BA) of 76%–82%. The validation of the models using an external test set proved that the models can be used to predict the activity of newly designed compounds with a reasonable accuracy within the applicability domain (BA = 83%–89%). The models were applied to screen a virtual chemical library with expected activity of compounds against MDR Acinetobacter baumannii. The eighteen most promising compounds were identified, synthesized, and tested. Biological testing of compounds was performed using the disk diffusion method in Mueller‐Hinton agar. All tested molecules demonstrated high anti‐A. baumannii activity and different toxicity levels. The developed classification SAR models are freely available online at http://ochem.eu/article/113921 and could be used by scientists for design of new more effective antibiotics.

  DOI：

  10.1111/cbdd.13678
• 作为产物：
  描述：

  N-(2,2,2-trichloro-1-hydroxyethyl)furan-2-carboxamide 在 氯化亚砜 作用下， 生成 N-(1,2,2,2-Tetrachloraethyl)-α-furoamid
  参考文献：
  名称：

  In silico and in vitro studies of a number PILs as new antibacterials against MDR clinical isolate Acinetobacter baumannii

  摘要：

  AbstractQSAR analysis of a set of previously synthesized phosphonium ionic liquids (PILs) tested against Gram‐negative multidrug‐resistant clinical isolate Acinetobacter baumannii was done using the Online Chemical Modeling Environment (OCHEM). To overcome the problem of overfitting due to descriptor selection, fivefold cross‐validation with variable selection in each step of the model development was applied. The predictive ability of the classification models was tested by cross‐validation, giving balanced accuracies (BA) of 76%–82%. The validation of the models using an external test set proved that the models can be used to predict the activity of newly designed compounds with a reasonable accuracy within the applicability domain (BA = 83%–89%). The models were applied to screen a virtual chemical library with expected activity of compounds against MDR Acinetobacter baumannii. The eighteen most promising compounds were identified, synthesized, and tested. Biological testing of compounds was performed using the disk diffusion method in Mueller‐Hinton agar. All tested molecules demonstrated high anti‐A. baumannii activity and different toxicity levels. The developed classification SAR models are freely available online at http://ochem.eu/article/113921 and could be used by scientists for design of new more effective antibiotics.

  DOI：

  10.1111/cbdd.13678

文献信息

• SUBSTITUTED METHYL AMINES, SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS, METHODS FOR PRODUCTION AND USE THEREOF
  申请人：Ivachtchenko Alexandre Vasilievich

  公开号：US20130267536A1

  公开（公告）日：2013-10-10

  The present invention relates to novel substituted methyl-amines, serotonin 5-HT 6 receptor antagonists, to active components, pharmaceutical compositions, method for prophylaxis and treatment of CNS diseases and “molecular tools”, in which novel substituted methyl-amines represent compounds of the general formula 1 and their crystalline forms and pharmaceutically acceptable salts, wherein: W represents benzene, naphthalene, indolizine, quinoline or oxazole cycle; R1=H, F, Cl; R2 represents hydrogen, fluoro, methyl, phenyl, thienyl, furan-2-yl, pyridyl, piperazin-1-yl or 4-methylpiperazin-1-yl; R3 represents cyclopropyl or optionally substituted methyl; with the exception of the compounds in which W simultaneously represents oxazole cycle and R2=phenyl or pyridyl.

  本发明涉及新型取代甲基胺，血清素5-HT6受体拮抗剂，活性成分，药物组合物，预防和治疗中枢神经系统疾病的方法和“分子工具”，其中新型取代甲基胺代表一般式1的化合物及其结晶形式和药用可接受盐， 其中：W代表苯，萘，吲哚啉，喹啉或噁唑环；R1=H，F，Cl；R2代表氢，氟，甲基，苯基，噻吩基，呋喃-2-基，吡啶基，哌嗪-1-基或4-甲基哌嗪-1-基；R3代表环丙基或可选择取代的甲基；除了W同时代表噁唑环且R2=苯基或吡啶基的化合物。
• SUBSTITUTED METHYL AMINES, SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS, METHODS FOR THE PRODUCTION AND USE THEREOF
  申请人：Ivachtchenko, Alexandre Vasilievich

  公开号：EP2657225A2

  公开（公告）日：2013-10-30

  The present invention relates to novel substituted methyl-amines, serotonin 5-HT6 receptor antagonists, to active components, pharmaceutical compositions, method for prophylaxis and treatment of CNS diseases and "molecular tools", in which novel substituted methyl-amines represent compounds of the general formula 1 and their crystalline forms and pharmaceutically acceptable salts, wherein: W represents benzene, naphthalene, indolizine, quinoline or oxazole cycle; R1 = H, F, Cl; R2 represents hydrogen, fluoro, methyl, phenyl, thienyl, furan-2-yl, pyridyl, piperazin-1-yl or 4-methylpiperazin-1-yl; R3 represents cyclopropyl or optionally substituted methyl; with the exception of the compounds in which W simultaneously represents oxazole cycle and R2 = phenyl or pyridyl.

  本发明涉及新型取代的甲基胺、5-羟色胺 5-HT6 受体拮抗剂、活性成分、药物组合物、预防和治疗中枢神经系统疾病的方法以及 "分子工具"，其中新型取代的甲基胺代表通式 1 的化合物及其结晶形式和药学上可接受的盐类、 其中 W 代表苯、萘、吲哚利嗪、喹啉或噁唑循环； R1 = H、F、Cl R2 代表氢、氟、甲基、苯基、噻吩基、呋喃-2-基、吡啶基、哌嗪-1-基或 4-甲基哌嗪-1-基；R3 代表环丙基或任选取代的甲基；W 同时代表噁唑环和 R2 = 苯基或吡啶基的化合物除外。
• Amidoalkylation of 2- and 4-hydroxy-pyrimidines with N-(1,2,2,2-tetra-chloroethyl)amides of carboxylic acids
  作者：L. P. Prikazchikova、L. I. Rybchenko、S. V. Klyuchko、V. V. Pirozhenko、B. S. Drach

  DOI：10.1007/bf01184892

  日期：1994.10
• Amidoalkylation of pyrimidine bases of nucleic acids
  作者：B. M. Khutova、S. V. Klyuchko、L. P. Prikazchikova

  DOI：10.1007/bf00480839

  日期：1991.4
• US8829002B2
  申请人：——

  公开号：US8829002B2

  公开（公告）日：2014-09-09